Cargando…

Senolytics: Potential for Alleviating Diabetes and Its Complications

Therapeutics that target cellular senescence, including novel “senolytic” compounds, hold significant promise for treating or preventing obesity-induced metabolic dysfunction, type 2 diabetes, and the multiple complications of diabetes and obesity. Senolytics selectively clear senescent cells, which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palmer, Allyson K, Tchkonia, Tamar, Kirkland, James L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Mini-Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234500/ https://www.ncbi.nlm.nih.gov/pubmed/33705532 http://dx.doi.org/10.1210/endocr/bqab058

Ejemplares similares

Senolytic drugs: from discovery to translation
por: Kirkland, J. L., et al.
Publicado: (2020)

Discovery, development, and future application of senolytics: theories and predictions
por: Wissler Gerdes, Erin O., et al.
Publicado: (2020)

Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice
por: Roos, Carolyn M., et al.
Publicado: (2016)

Targeting cellular senescence in metabolic disease
por: Palmer, Allyson K., et al.
Publicado: (2022)

Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
por: Zhu, Yi, et al.
Publicado: (2022)

Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
por: Justice, Jamie N., et al.
Publicado: (2019)

Aging, Senescent Cells, and Senolytic Drugs: The Path to Translation
por: Kirkland, James
Publicado: (2020)

Senolytics Improve Physical Function and Increase Lifespan in Old Age
por: Xu, Ming, et al.
Publicado: (2018)

The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs
por: Zhu, Yi, et al.
Publicado: (2015)

Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
por: Zhu, Yi, et al.
Publicado: (2016)

Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer’s disease
por: Gonzales, Mitzi M., et al.
Publicado: (2023)

Senolytic Therapy to Modulate the Progression of Alzheimer’s Disease (SToMP-AD): A Pilot Clinical Trial
por: Gonzales, Mitzi M., et al.
Publicado: (2021)

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015)

Identification of HSP90 inhibitors as a novel class of senolytics
por: Fuhrmann-Stroissnigg, Heike, et al.
Publicado: (2017)

Therapeutic Potential of Senolytics in Cardiovascular Disease
por: Dookun, Emily, et al.
Publicado: (2020)

Senolytics reduce coronavirus-related mortality in old mice
por: Camell, Christina D., et al.
Publicado: (2021)

Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation
por: Iske, Jasper, et al.
Publicado: (2020)

Senolytics in the treatment of diabetic retinopathy
por: Hassan, Jannah Waled, et al.
Publicado: (2022)

Senolytics alleviate the degenerative disorders of temporomandibular joint in old age
por: Zhou, Yueying, et al.
Publicado: (2021)

Senolytics: Eliminating Senescent Cells and Alleviating Intervertebral Disc Degeneration
por: Wu, Yuhao, et al.
Publicado: (2022)

‘Sugarcoating’ 2-deoxyglucose: mechanisms that suppress its toxic effects
por: Schmidt, Martin C., et al.
Publicado: (2020)

Cellular senescence: at the nexus between ageing and diabetes
por: Palmer, Allyson K., et al.
Publicado: (2019)

Mitochondrial Aging and Senolytic Natural Products with Protective Potential
por: Deledda, Andrea, et al.
Publicado: (2022)

The ageing immune system as a potential target of senolytics
por: Du, Peter Yandi, et al.
Publicado: (2023)

Paradoxes of senolytics
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Strategies for senolytic drug discovery
por: Power, Helen, et al.
Publicado: (2023)

Senescence and Senolytics: State of the Art on Cellular Senescence, Senolytics, and Healthspan
por: Campisi, Judith
Publicado: (2020)

Cellular Senescence: A Translational Perspective
por: Kirkland, James L., et al.
Publicado: (2017)

NAD(+), Senolytics, or Pyruvate for Healthy Aging?
por: Zhou, Fang-Qiang
Publicado: (2021)

Fisetin for COVID‐19 in skilled nursing facilities: Senolytic trials in the COVID era
por: Verdoorn, Brandon P., et al.
Publicado: (2021)

Senolytics: A Novel Strategy for Neuroprotection in ALS?
por: Maximova, Alexandra, et al.
Publicado: (2021)

Palmitate induces DNA damage and senescence in human adipocytes in vitro that can be alleviated by oleic acid but not inorganic nitrate
por: Ishaq, Abbas, et al.
Publicado: (2022)

Senescence‐induced changes in CD4 T cell differentiation can be alleviated by treatment with senolytics
por: Lorenzo, Erica C., et al.
Publicado: (2021)

Statin induced diabetes and its clinical implications
por: Aiman, Umme, et al.
Publicado: (2014)

Alleviation of halitosis by use of probiotics and their protective mechanisms in the oral cavity
por: Karbalaei, M., et al.
Publicado: (2021)

Anti-aging: senolytics or gerostatics (unconventional view)
por: Blagosklonny, Mikhail V.
Publicado: (2021)

Role of mTOR Complex 1 Signaling Pathway in the Pathogenesis of Diabetes Complications; A Mini Review
por: Yarahmadi, Amir, et al.
Publicado: (2021)

Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
por: Hickson, LaTonya J., et al.
Publicado: (2019)

Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
por: Nambiar, Anoop, et al.
Publicado: (2023)

Complications associated with percutaneous nephrolithotomy
por: Taylor, Eric, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f0g6phbhs7t6hu5ddnl0q9ee20